# Carmine Zoccali

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carmine-zoccali/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,698 |
| Field | Dialysis and Renal Disease Management |
| h-index | 121 |
| i10-index | 639 |
| Last Known Institution | Università Campus Bio-Medico |
| OpenAlex ID | https://openalex.org/A5054081924 |
| ORCID iD | 0000-0002-6616-1996 |
| Works | 1,409 |

## Researcher papers

Showing 12 of 25.

- [Obesity and Kidney Disease: Hidden Consequences of the Epidemic](https://scholariq.org/papers/obesity-and-kidney-disease-hidden-consequences-of-the-epidemic/)
- [Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study](https://scholariq.org/papers/plasma-concentration-of-asymmetrical-dimethylarginine-and-mortality-in-patients/)
- [A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases](https://scholariq.org/papers/a-single-number-for-advocacy-and-communication-worldwide-more-than-850-million-2/)
- [Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria](https://scholariq.org/papers/renoprotective-properties-of-ace-inhibition-in-non-diabetic-nephropathies-with/)
- [An introduction to inverse probability of treatment weighting in observational research](https://scholariq.org/papers/an-introduction-to-inverse-probability-of-treatment-weighting-in-observational/)
- [External validation of prognostic models: what, why, how, when and where?](https://scholariq.org/papers/external-validation-of-prognostic-models-what-why-how-when-and-where/)
- [Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease](https://scholariq.org/papers/adiponectin-metabolic-risk-factors-and-cardiovascular-events-among-patients-with/)
- [Oxidative stress in end-stage renal disease: an emerging threat to patient outcome](https://scholariq.org/papers/oxidative-stress-in-end-stage-renal-disease-an-emerging-threat-to-patient/)
- [When do we need competing risks methods for survival analysis in nephrology?](https://scholariq.org/papers/when-do-we-need-competing-risks-methods-for-survival-analysis-in-nephrology/)
- [Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial](https://scholariq.org/papers/blood-pressure-control-for-renoprotection-in-patients-with-non-diabetic-chronic/)
- [A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases](https://scholariq.org/papers/a-single-number-for-advocacy-and-communication-worldwide-more-than-850-million/)
- [CKD Prevalence Varies across the European General Population](https://scholariq.org/papers/ckd-prevalence-varies-across-the-european-general-population/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [Università Campus Bio-Medico](https://scholariq.org/institutions/universita-campus-bio-medico/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.